EUVIMEDEUVIMED entdecken
Crossref

Liquid biopsy for CNS lymphoma: CSF exosomes and CSF exosomal miR-15a, miR-21, miR-155, miR-210, and miR-19b are promising biomarkers for diagnosis

Mustafa Aziz Hatiboglu, Busra Karacam, Imran Khan, Kerime Akdur, Elif Burce Elbasan, Sadaf Mahfooz, Mehmet Hakan Seyithanoglu, Guven Cetin, Meliha Gundag Papaker, Mustafa Namik Oztanir

Molecular Biology Reports · 2024

DOI: 10.1007/s11033-024-09967-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Mustafa Aziz Hatiboglu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Bezmialem Vakif University Medical School, Vatan Street, Fatih, Istanbul, Turkey. azizhatiboglu@yahoo.com. Hauptthemen laut MEDLINE: Exosomes, MicroRNAs, Central Nervous System Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Bezmialem Vakıf Üniversitesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Central nervous system lymphoma (CNSL) is a devastating disease with a poor prognosis. Early diagnosis, monitoring of the treatment response, and outcome prediction carry the utmost importance in the management of patients with CNSL. Surgical biopsy is the gold standard for tissue diagnosis, however, this procedure has potential complications. Therefore, there is a need for a method that provides information about diagnosis and patient monitoring to avoid surgical risks. The study aimed to investigate potential diagnostic biomarkers for patients with CNSL. METHODS AND RESULTS: Patients with secondary CNSL were included in this study. Serum and cerebrospinal fluid (CSF) samples were collected before treatment and after completion of the treatment. Cell-free DNA (cfDNA), exosomes, free and exosomal microRNA (miR)-15a, miR-21, miR-155, miR-210, and miR-19b in both serum and CSF were examined, and they were compared with the controls. Also, their levels before and after treatment were compared. Nine patients with the diagnosis of secondary CNSL were reviewed. cfDNA, miR-15a, and miR-155 in serum, and exosome in CSF were found to be significantly higher in CNSL patients compared to the controls. Exosomal miR-15a, miR-21, miR-155, miR-210, and miR-19b in CSF were found to be significantly higher in CNSL patients compared to controls, whereas their levels in serum were not significantly high. CONCLUSIONS: Our findings suggested that exosomes and exosomal miR-15a, miR-21, miR-155, miR-210 and miR-19b in CSF would be promising biomarkers for the diagnosis of patients with CNSL. Further studies are needed to confirm our findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesMicroRNAsCentral Nervous System NeoplasmsBiomarkers, TumorLymphomaHumansLiquid BiopsyMaleFemaleMiddle AgedAdultAgedCell-Free Nucleic Acids

Stichwörter der Autor:innen

BiomarkerCNS lymphomaExosomeLiquid biopsycfDNAmiRNA

Substanzen

MicroRNAsBiomarkers, TumorMIRN21 microRNA, humanMIRN155 microRNA, humanCell-Free Nucleic AcidsMIRN210 microRNA, humanMIRN15 microRNA, human

Autor:innen und Institutionen

  • Department of Neurosurgery, Bezmialem Vakif University Medical School, Vatan Street, Fatih, Istanbul, Turkey. azizhatiboglu@yahoo.com.
  • Department of Molecular Biology, Beykoz Institute of Life Sciences and Biotechnology, Bezmialem Vakif University, Yalikoy, Beykoz, Istanbul, Turkey. azizhatiboglu@yahoo.com.
  • Department of Molecular Biology, Beykoz Institute of Life Sciences and Biotechnology, Bezmialem Vakif University, Yalikoy, Beykoz, Istanbul, Turkey.
  • Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.
  • Department of Neurosurgery, Bezmialem Vakif University Medical School, Vatan Street, Fatih, Istanbul, Turkey.
  • Department of Hematology, Bezmialem Vakif University Medical School, Vatan Street, Fatih, Istanbul, Turkey.

Förderung

  • Bezmialem Vakıf Üniversitesi

Zitieren

APA

Hatiboglu, M. A., Karacam, B., Khan, I., Akdur, K., Elbasan, E. B., Mahfooz, S., Seyithanoglu, M. H., Cetin, G., Papaker, M. G., & Oztanir, M. N. (2024). Liquid biopsy for CNS lymphoma: CSF exosomes and CSF exosomal miR-15a, miR-21, miR-155, miR-210, and miR-19b are promising biomarkers for diagnosis. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09967-8

Vancouver

Hatiboglu MA, Karacam B, Khan I, Akdur K, Elbasan EB, Mahfooz S, et al. Liquid biopsy for CNS lymphoma: CSF exosomes and CSF exosomal miR-15a, miR-21, miR-155, miR-210, and miR-19b are promising biomarkers for diagnosis. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09967-8

BibTeX
@article{Hatiboglu2024,
  author = {Hatiboglu, Mustafa Aziz and Karacam, Busra and Khan, Imran and Akdur, Kerime and Elbasan, Elif Burce and Mahfooz, Sadaf and Seyithanoglu, Mehmet Hakan and Cetin, Guven and Papaker, Meliha Gundag and Oztanir, Mustafa Namik},
  title = {Liquid biopsy for CNS lymphoma: CSF exosomes and CSF exosomal miR-15a, miR-21, miR-155, miR-210, and miR-19b are promising biomarkers for diagnosis},
  journal = {Molecular Biology Reports},
  year = {2024},
  doi = {10.1007/s11033-024-09967-8}
}
Kostenlos starten →